DiaSorin S.p.A.
DiaSorin S.p.A. DSRLF Peers
See (DSRLF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DSRLF | $104.69 | N/A | 5.6B | 26.57 | $3.94 | +1.31% |
| LZAGY | $69.60 | +2.08% | 50.2B | 63.85 | $1.09 | +0.74% |
| LZAGF | $705.26 | +2.90% | 49.6B | 65.97 | $10.69 | +0.41% |
| WUXAY | $8.73 | -1.58% | 25B | 16.17 | $0.54 | +0.72% |
| WUXIF | $7.34 | N/A | 20.7B | 13.59 | $0.54 | +2.54% |
| BMXMF | $136.00 | +1.30% | 16B | 32.93 | $4.13 | +0.68% |
| ERFSF | $67.36 | +0.01% | 11.9B | 28.30 | $2.38 | +1.57% |
| SKHCF | $18.08 | +10.31% | 8.7B | 24.77 | $0.73 | +3.88% |
| SKHHY | $17.28 | -0.46% | 8.3B | 23.67 | $0.73 | +3.91% |
| HNGZY | $4.00 | N/A | 5.1B | 26.67 | $0.15 | +1.99% |
Stock Comparison
DSRLF vs LZAGY Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, LZAGY has a market cap of 50.2B. Regarding current trading prices, DSRLF is priced at $104.69, while LZAGY trades at $69.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas LZAGY's P/E ratio is 63.85. In terms of profitability, DSRLF's ROE is +0.09%, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, DSRLF is more volatile compared to LZAGY. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs LZAGF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, LZAGF has a market cap of 49.6B. Regarding current trading prices, DSRLF is priced at $104.69, while LZAGF trades at $705.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas LZAGF's P/E ratio is 65.97. In terms of profitability, DSRLF's ROE is +0.09%, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, DSRLF is less volatile compared to LZAGF. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs WUXAY Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, WUXAY has a market cap of 25B. Regarding current trading prices, DSRLF is priced at $104.69, while WUXAY trades at $8.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas WUXAY's P/E ratio is 16.17. In terms of profitability, DSRLF's ROE is +0.09%, compared to WUXAY's ROE of +0.19%. Regarding short-term risk, DSRLF is more volatile compared to WUXAY. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs WUXIF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, WUXIF has a market cap of 20.7B. Regarding current trading prices, DSRLF is priced at $104.69, while WUXIF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas WUXIF's P/E ratio is 13.59. In terms of profitability, DSRLF's ROE is +0.09%, compared to WUXIF's ROE of +0.19%. Regarding short-term risk, DSRLF is more volatile compared to WUXIF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs BMXMF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, BMXMF has a market cap of 16B. Regarding current trading prices, DSRLF is priced at $104.69, while BMXMF trades at $136.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas BMXMF's P/E ratio is 32.93. In terms of profitability, DSRLF's ROE is +0.09%, compared to BMXMF's ROE of +0.10%. Regarding short-term risk, DSRLF is more volatile compared to BMXMF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs ERFSF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, ERFSF has a market cap of 11.9B. Regarding current trading prices, DSRLF is priced at $104.69, while ERFSF trades at $67.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas ERFSF's P/E ratio is 28.30. In terms of profitability, DSRLF's ROE is +0.09%, compared to ERFSF's ROE of +0.07%. Regarding short-term risk, DSRLF is less volatile compared to ERFSF. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs SKHCF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, SKHCF has a market cap of 8.7B. Regarding current trading prices, DSRLF is priced at $104.69, while SKHCF trades at $18.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas SKHCF's P/E ratio is 24.77. In terms of profitability, DSRLF's ROE is +0.09%, compared to SKHCF's ROE of +0.05%. Regarding short-term risk, DSRLF is more volatile compared to SKHCF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs SKHHY Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, SKHHY has a market cap of 8.3B. Regarding current trading prices, DSRLF is priced at $104.69, while SKHHY trades at $17.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas SKHHY's P/E ratio is 23.67. In terms of profitability, DSRLF's ROE is +0.09%, compared to SKHHY's ROE of +0.07%. Regarding short-term risk, DSRLF is more volatile compared to SKHHY. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs HNGZY Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, HNGZY has a market cap of 5.1B. Regarding current trading prices, DSRLF is priced at $104.69, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, DSRLF's ROE is +0.09%, compared to HNGZY's ROE of +0.02%. Regarding short-term risk, DSRLF is more volatile compared to HNGZY. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs VIMGF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, VIMGF has a market cap of 1.8B. Regarding current trading prices, DSRLF is priced at $104.69, while VIMGF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas VIMGF's P/E ratio is 70.00. In terms of profitability, DSRLF's ROE is +0.09%, compared to VIMGF's ROE of +0.03%. Regarding short-term risk, DSRLF is more volatile compared to VIMGF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs MRCHF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, MRCHF has a market cap of 1.2B. Regarding current trading prices, DSRLF is priced at $104.69, while MRCHF trades at $21.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas MRCHF's P/E ratio is 61.83. In terms of profitability, DSRLF's ROE is +0.09%, compared to MRCHF's ROE of -0.04%. Regarding short-term risk, DSRLF is less volatile compared to MRCHF. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs IDGXF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, IDGXF has a market cap of 186M. Regarding current trading prices, DSRLF is priced at $104.69, while IDGXF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas IDGXF's P/E ratio is 8.00. In terms of profitability, DSRLF's ROE is +0.09%, compared to IDGXF's ROE of +0.24%. Regarding short-term risk, DSRLF is less volatile compared to IDGXF. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs EDTXF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, EDTXF has a market cap of 172.6M. Regarding current trading prices, DSRLF is priced at $104.69, while EDTXF trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas EDTXF's P/E ratio is -10.09. In terms of profitability, DSRLF's ROE is +0.09%, compared to EDTXF's ROE of +0.79%. Regarding short-term risk, DSRLF is more volatile compared to EDTXF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs AMCY Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, AMCY has a market cap of 171.3M. Regarding current trading prices, DSRLF is priced at $104.69, while AMCY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas AMCY's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to AMCY's ROE of N/A. Regarding short-term risk, DSRLF is more volatile compared to AMCY. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs NNGRF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, NNGRF has a market cap of 164.3M. Regarding current trading prices, DSRLF is priced at $104.69, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, DSRLF's ROE is +0.09%, compared to NNGRF's ROE of -0.07%. Regarding short-term risk, DSRLF is more volatile compared to NNGRF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs CORBF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, CORBF has a market cap of 158.7M. Regarding current trading prices, DSRLF is priced at $104.69, while CORBF trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas CORBF's P/E ratio is 3.59. In terms of profitability, DSRLF's ROE is +0.09%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, DSRLF is less volatile compared to CORBF. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs THOXF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, THOXF has a market cap of 130.9M. Regarding current trading prices, DSRLF is priced at $104.69, while THOXF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas THOXF's P/E ratio is -14.40. In terms of profitability, DSRLF's ROE is +0.09%, compared to THOXF's ROE of -0.91%. Regarding short-term risk, DSRLF is less volatile compared to THOXF. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs DIUXF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, DIUXF has a market cap of 115.5M. Regarding current trading prices, DSRLF is priced at $104.69, while DIUXF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas DIUXF's P/E ratio is 136.72. In terms of profitability, DSRLF's ROE is +0.09%, compared to DIUXF's ROE of -0.07%. Regarding short-term risk, DSRLF is more volatile compared to DIUXF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs ANPCF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, ANPCF has a market cap of 100M. Regarding current trading prices, DSRLF is priced at $104.69, while ANPCF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas ANPCF's P/E ratio is -3.10. In terms of profitability, DSRLF's ROE is +0.09%, compared to ANPCF's ROE of -0.54%. Regarding short-term risk, DSRLF is less volatile compared to ANPCF. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs TIHE Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, TIHE has a market cap of 71.9M. Regarding current trading prices, DSRLF is priced at $104.69, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas TIHE's P/E ratio is 0.32. In terms of profitability, DSRLF's ROE is +0.09%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, DSRLF is more volatile compared to TIHE. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs BIOGF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, BIOGF has a market cap of 65.4M. Regarding current trading prices, DSRLF is priced at $104.69, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, DSRLF's ROE is +0.09%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, DSRLF is more volatile compared to BIOGF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs PCNEF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, PCNEF has a market cap of 62M. Regarding current trading prices, DSRLF is priced at $104.69, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, DSRLF's ROE is +0.09%, compared to PCNEF's ROE of -0.21%. Regarding short-term risk, DSRLF is more volatile compared to PCNEF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs PFGTF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, PFGTF has a market cap of 50.6M. Regarding current trading prices, DSRLF is priced at $104.69, while PFGTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas PFGTF's P/E ratio is -3.11. In terms of profitability, DSRLF's ROE is +0.09%, compared to PFGTF's ROE of -0.41%. Regarding short-term risk, DSRLF is more volatile compared to PFGTF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs CLIFF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, CLIFF has a market cap of 44.1M. Regarding current trading prices, DSRLF is priced at $104.69, while CLIFF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas CLIFF's P/E ratio is -2.87. In terms of profitability, DSRLF's ROE is +0.09%, compared to CLIFF's ROE of -0.08%. Regarding short-term risk, DSRLF is more volatile compared to CLIFF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs BIOQ Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, BIOQ has a market cap of 39.6M. Regarding current trading prices, DSRLF is priced at $104.69, while BIOQ trades at $44.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas BIOQ's P/E ratio is 15.58. In terms of profitability, DSRLF's ROE is +0.09%, compared to BIOQ's ROE of -0.06%. Regarding short-term risk, DSRLF is more volatile compared to BIOQ. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs ANPCY Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, ANPCY has a market cap of 31.2M. Regarding current trading prices, DSRLF is priced at $104.69, while ANPCY trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas ANPCY's P/E ratio is -1.49. In terms of profitability, DSRLF's ROE is +0.09%, compared to ANPCY's ROE of -0.75%. Regarding short-term risk, DSRLF is less volatile compared to ANPCY. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs SNANF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, SNANF has a market cap of 30.3M. Regarding current trading prices, DSRLF is priced at $104.69, while SNANF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas SNANF's P/E ratio is -14.00. In terms of profitability, DSRLF's ROE is +0.09%, compared to SNANF's ROE of -2.51%. Regarding short-term risk, DSRLF is more volatile compared to SNANF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs IMMVF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, IMMVF has a market cap of 22.6M. Regarding current trading prices, DSRLF is priced at $104.69, while IMMVF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas IMMVF's P/E ratio is -0.32. In terms of profitability, DSRLF's ROE is +0.09%, compared to IMMVF's ROE of -2.69%. Regarding short-term risk, DSRLF is less volatile compared to IMMVF. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs PCHM Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, PCHM has a market cap of 21.9M. Regarding current trading prices, DSRLF is priced at $104.69, while PCHM trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas PCHM's P/E ratio is -0.02. In terms of profitability, DSRLF's ROE is +0.09%, compared to PCHM's ROE of +0.53%. Regarding short-term risk, DSRLF is more volatile compared to PCHM. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs BMKDF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, BMKDF has a market cap of 21.1M. Regarding current trading prices, DSRLF is priced at $104.69, while BMKDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas BMKDF's P/E ratio is -23.17. In terms of profitability, DSRLF's ROE is +0.09%, compared to BMKDF's ROE of +2.24%. Regarding short-term risk, DSRLF is more volatile compared to BMKDF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs VILGF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, VILGF has a market cap of 20.7M. Regarding current trading prices, DSRLF is priced at $104.69, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas VILGF's P/E ratio is -0.30. In terms of profitability, DSRLF's ROE is +0.09%, compared to VILGF's ROE of N/A. Regarding short-term risk, DSRLF is more volatile compared to VILGF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs LDXHF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, LDXHF has a market cap of 19.5M. Regarding current trading prices, DSRLF is priced at $104.69, while LDXHF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas LDXHF's P/E ratio is -2.60. In terms of profitability, DSRLF's ROE is +0.09%, compared to LDXHF's ROE of -1.38%. Regarding short-term risk, DSRLF is less volatile compared to LDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs PMSNF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, PMSNF has a market cap of 14.8M. Regarding current trading prices, DSRLF is priced at $104.69, while PMSNF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas PMSNF's P/E ratio is -2.50. In terms of profitability, DSRLF's ROE is +0.09%, compared to PMSNF's ROE of +0.69%. Regarding short-term risk, DSRLF is more volatile compared to PMSNF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs ABDXF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, ABDXF has a market cap of 13.6M. Regarding current trading prices, DSRLF is priced at $104.69, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, DSRLF's ROE is +0.09%, compared to ABDXF's ROE of -0.63%. Regarding short-term risk, DSRLF is more volatile compared to ABDXF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs IZOZF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, IZOZF has a market cap of 11.6M. Regarding current trading prices, DSRLF is priced at $104.69, while IZOZF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas IZOZF's P/E ratio is -6.39. In terms of profitability, DSRLF's ROE is +0.09%, compared to IZOZF's ROE of +0.47%. Regarding short-term risk, DSRLF is more volatile compared to IZOZF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs MXDHF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, MXDHF has a market cap of 8.6M. Regarding current trading prices, DSRLF is priced at $104.69, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, DSRLF's ROE is +0.09%, compared to MXDHF's ROE of -6.91%. Regarding short-term risk, DSRLF is more volatile compared to MXDHF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs VRCDF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, VRCDF has a market cap of 7.3M. Regarding current trading prices, DSRLF is priced at $104.69, while VRCDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas VRCDF's P/E ratio is -1.00. In terms of profitability, DSRLF's ROE is +0.09%, compared to VRCDF's ROE of -0.73%. Regarding short-term risk, DSRLF is less volatile compared to VRCDF. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs SQIDF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, SQIDF has a market cap of 6.1M. Regarding current trading prices, DSRLF is priced at $104.69, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, DSRLF's ROE is +0.09%, compared to SQIDF's ROE of +4.47%. Regarding short-term risk, DSRLF is less volatile compared to SQIDF. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs TDSGF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, TDSGF has a market cap of 5.7M. Regarding current trading prices, DSRLF is priced at $104.69, while TDSGF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas TDSGF's P/E ratio is -1.90. In terms of profitability, DSRLF's ROE is +0.09%, compared to TDSGF's ROE of -3.19%. Regarding short-term risk, DSRLF is more volatile compared to TDSGF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs SLDX Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, SLDX has a market cap of 4.8M. Regarding current trading prices, DSRLF is priced at $104.69, while SLDX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas SLDX's P/E ratio is -0.01. In terms of profitability, DSRLF's ROE is +0.09%, compared to SLDX's ROE of +0.06%. Regarding short-term risk, DSRLF is less volatile compared to SLDX. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs RNVA Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, RNVA has a market cap of 4.3M. Regarding current trading prices, DSRLF is priced at $104.69, while RNVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas RNVA's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to RNVA's ROE of +0.23%. Regarding short-term risk, DSRLF is more volatile compared to RNVA. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs AVCRF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, AVCRF has a market cap of 4.3M. Regarding current trading prices, DSRLF is priced at $104.69, while AVCRF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas AVCRF's P/E ratio is -4.23. In terms of profitability, DSRLF's ROE is +0.09%, compared to AVCRF's ROE of +0.05%. Regarding short-term risk, DSRLF is less volatile compared to AVCRF. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs JMPHF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, JMPHF has a market cap of 4.2M. Regarding current trading prices, DSRLF is priced at $104.69, while JMPHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas JMPHF's P/E ratio is -0.91. In terms of profitability, DSRLF's ROE is +0.09%, compared to JMPHF's ROE of -0.11%. Regarding short-term risk, DSRLF is less volatile compared to JMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs ICBU Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, ICBU has a market cap of 3.7M. Regarding current trading prices, DSRLF is priced at $104.69, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas ICBU's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to ICBU's ROE of +0.70%. Regarding short-term risk, DSRLF is less volatile compared to ICBU. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs GNTLF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, GNTLF has a market cap of 3.7M. Regarding current trading prices, DSRLF is priced at $104.69, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, DSRLF's ROE is +0.09%, compared to GNTLF's ROE of -3.62%. Regarding short-term risk, DSRLF is more volatile compared to GNTLF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs SZLSF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, SZLSF has a market cap of 3.6M. Regarding current trading prices, DSRLF is priced at $104.69, while SZLSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas SZLSF's P/E ratio is -0.02. In terms of profitability, DSRLF's ROE is +0.09%, compared to SZLSF's ROE of +0.13%. Regarding short-term risk, DSRLF is less volatile compared to SZLSF. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs IDXG Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, IDXG has a market cap of 3.5M. Regarding current trading prices, DSRLF is priced at $104.69, while IDXG trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas IDXG's P/E ratio is 2.79. In terms of profitability, DSRLF's ROE is +0.09%, compared to IDXG's ROE of -1.19%. Regarding short-term risk, DSRLF is more volatile compared to IDXG. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs IDTA Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, IDTA has a market cap of 1.7M. Regarding current trading prices, DSRLF is priced at $104.69, while IDTA trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas IDTA's P/E ratio is 4.15. In terms of profitability, DSRLF's ROE is +0.09%, compared to IDTA's ROE of +0.36%. Regarding short-term risk, DSRLF is less volatile compared to IDTA. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs IBXXF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, IBXXF has a market cap of 1.6M. Regarding current trading prices, DSRLF is priced at $104.69, while IBXXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas IBXXF's P/E ratio is -0.27. In terms of profitability, DSRLF's ROE is +0.09%, compared to IBXXF's ROE of +0.55%. Regarding short-term risk, DSRLF is less volatile compared to IBXXF. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs IVRO Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, IVRO has a market cap of 1.6M. Regarding current trading prices, DSRLF is priced at $104.69, while IVRO trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas IVRO's P/E ratio is -0.77. In terms of profitability, DSRLF's ROE is +0.09%, compared to IVRO's ROE of +0.08%. Regarding short-term risk, DSRLF is less volatile compared to IVRO. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs NSTM Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, NSTM has a market cap of 1.2M. Regarding current trading prices, DSRLF is priced at $104.69, while NSTM trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas NSTM's P/E ratio is -0.44. In terms of profitability, DSRLF's ROE is +0.09%, compared to NSTM's ROE of +0.87%. Regarding short-term risk, DSRLF is more volatile compared to NSTM. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs DIGP Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, DIGP has a market cap of 1.1M. Regarding current trading prices, DSRLF is priced at $104.69, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas DIGP's P/E ratio is -1.04. In terms of profitability, DSRLF's ROE is +0.09%, compared to DIGP's ROE of +3.08%. Regarding short-term risk, DSRLF is less volatile compared to DIGP. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs SCRSF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, SCRSF has a market cap of 906.3K. Regarding current trading prices, DSRLF is priced at $104.69, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas SCRSF's P/E ratio is -0.09. In terms of profitability, DSRLF's ROE is +0.09%, compared to SCRSF's ROE of +2.91%. Regarding short-term risk, DSRLF is more volatile compared to SCRSF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs RSHN Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, RSHN has a market cap of 817.5K. Regarding current trading prices, DSRLF is priced at $104.69, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas RSHN's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, DSRLF is more volatile compared to RSHN. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs EPGNF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, EPGNF has a market cap of 692.8K. Regarding current trading prices, DSRLF is priced at $104.69, while EPGNF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas EPGNF's P/E ratio is -0.04. In terms of profitability, DSRLF's ROE is +0.09%, compared to EPGNF's ROE of -4.14%. Regarding short-term risk, DSRLF is more volatile compared to EPGNF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs MBGNF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, MBGNF has a market cap of 172.6K. Regarding current trading prices, DSRLF is priced at $104.69, while MBGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas MBGNF's P/E ratio is -1.00. In terms of profitability, DSRLF's ROE is +0.09%, compared to MBGNF's ROE of +0.37%. Regarding short-term risk, DSRLF is more volatile compared to MBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs NVTAQ Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, NVTAQ has a market cap of 85.9K. Regarding current trading prices, DSRLF is priced at $104.69, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, DSRLF's ROE is +0.09%, compared to NVTAQ's ROE of +0.00%. Regarding short-term risk, DSRLF is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs ARYC Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, ARYC has a market cap of 79.3K. Regarding current trading prices, DSRLF is priced at $104.69, while ARYC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas ARYC's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to ARYC's ROE of +0.55%. Regarding short-term risk, DSRLF is less volatile compared to ARYC. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs HCLC Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, HCLC has a market cap of 74K. Regarding current trading prices, DSRLF is priced at $104.69, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas HCLC's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, DSRLF is more volatile compared to HCLC. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs MEDVF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, MEDVF has a market cap of 54K. Regarding current trading prices, DSRLF is priced at $104.69, while MEDVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas MEDVF's P/E ratio is -0.03. In terms of profitability, DSRLF's ROE is +0.09%, compared to MEDVF's ROE of +0.57%. Regarding short-term risk, DSRLF is more volatile compared to MEDVF. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs CHHL Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, CHHL has a market cap of 37.3K. Regarding current trading prices, DSRLF is priced at $104.69, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas CHHL's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to CHHL's ROE of +0.00%. Regarding short-term risk, DSRLF is less volatile compared to CHHL. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs IHTI Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, IHTI has a market cap of 32.5K. Regarding current trading prices, DSRLF is priced at $104.69, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas IHTI's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, DSRLF is less volatile compared to IHTI. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs MEDD Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, MEDD has a market cap of 31.9K. Regarding current trading prices, DSRLF is priced at $104.69, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas MEDD's P/E ratio is -0.01. In terms of profitability, DSRLF's ROE is +0.09%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, DSRLF is more volatile compared to MEDD. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs TOMDF Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, TOMDF has a market cap of 14.1K. Regarding current trading prices, DSRLF is priced at $104.69, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas TOMDF's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, DSRLF is less volatile compared to TOMDF. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs ABMC Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, ABMC has a market cap of 4.8K. Regarding current trading prices, DSRLF is priced at $104.69, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas ABMC's P/E ratio is 0.01. In terms of profitability, DSRLF's ROE is +0.09%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, DSRLF is more volatile compared to ABMC. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs RGDXQ Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, RGDXQ has a market cap of 3.9K. Regarding current trading prices, DSRLF is priced at $104.69, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, DSRLF is less volatile compared to RGDXQ. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs GWHP Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, GWHP has a market cap of 1.3K. Regarding current trading prices, DSRLF is priced at $104.69, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas GWHP's P/E ratio is -0.00. In terms of profitability, DSRLF's ROE is +0.09%, compared to GWHP's ROE of +0.00%. Regarding short-term risk, DSRLF is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs CGNH Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, CGNH has a market cap of 1.2K. Regarding current trading prices, DSRLF is priced at $104.69, while CGNH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas CGNH's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to CGNH's ROE of +1.41%. Regarding short-term risk, DSRLF is more volatile compared to CGNH. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs CYPS Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, CYPS has a market cap of 811. Regarding current trading prices, DSRLF is priced at $104.69, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas CYPS's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to CYPS's ROE of N/A. Regarding short-term risk, DSRLF is less volatile compared to CYPS. This indicates potentially lower risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs ROSGQ Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, ROSGQ has a market cap of 593. Regarding current trading prices, DSRLF is priced at $104.69, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to ROSGQ's ROE of -1.35%. Regarding short-term risk, DSRLF is more volatile compared to ROSGQ. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs BIOCQ Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, BIOCQ has a market cap of 263. Regarding current trading prices, DSRLF is priced at $104.69, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas BIOCQ's P/E ratio is -0.00. In terms of profitability, DSRLF's ROE is +0.09%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, DSRLF is more volatile compared to BIOCQ. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs HTGMQ Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, HTGMQ has a market cap of 221. Regarding current trading prices, DSRLF is priced at $104.69, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, DSRLF is more volatile compared to HTGMQ. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs DMTKQ Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, DMTKQ has a market cap of 35. Regarding current trading prices, DSRLF is priced at $104.69, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas DMTKQ's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to DMTKQ's ROE of -0.80%. Regarding short-term risk, DSRLF is more volatile compared to DMTKQ. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs OPGX Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, OPGX has a market cap of 17. Regarding current trading prices, DSRLF is priced at $104.69, while OPGX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas OPGX's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, DSRLF is more volatile compared to OPGX. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs MRPS Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, MRPS has a market cap of 0. Regarding current trading prices, DSRLF is priced at $104.69, while MRPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas MRPS's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to MRPS's ROE of N/A. Regarding short-term risk, DSRLF is more volatile compared to MRPS. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs BGNX Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, BGNX has a market cap of 0. Regarding current trading prices, DSRLF is priced at $104.69, while BGNX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas BGNX's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to BGNX's ROE of N/A. Regarding short-term risk, DSRLF is more volatile compared to BGNX. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs AGHC Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, AGHC has a market cap of 0. Regarding current trading prices, DSRLF is priced at $104.69, while AGHC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas AGHC's P/E ratio is N/A. In terms of profitability, DSRLF's ROE is +0.09%, compared to AGHC's ROE of +2.90%. Regarding short-term risk, DSRLF is more volatile compared to AGHC. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.
DSRLF vs EPGNY Comparison
DSRLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSRLF stands at 5.6B. In comparison, EPGNY has a market cap of 0. Regarding current trading prices, DSRLF is priced at $104.69, while EPGNY trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSRLF currently has a P/E ratio of 26.57, whereas EPGNY's P/E ratio is -1.60. In terms of profitability, DSRLF's ROE is +0.09%, compared to EPGNY's ROE of -0.19%. Regarding short-term risk, DSRLF is more volatile compared to EPGNY. This indicates potentially higher risk in terms of short-term price fluctuations for DSRLF.